The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monthly Archives: April 2011

Friday Science Review: April 29, 2011

Gene Transfer Restores Regenerative Power to Circulating Angiogenic Cells St. Michael’s Hospital ♦ University of Toronto Published in Molecular Therapy, April 26, 2011 An interesting new approach to autologous cell therapy for patients with coronary artery disease uses gene transfer to enhance the regenerative activity of circulating angiogenic cells (CACs). These rare cells circulate freely [...]

Q1 2011 Canadian Healthcare Review: some financing carry-over from the strong Q4 2010

The ‘Q1 2011 Canadian Healthcare Review’, which I [Wayne Schnarr] co-author with Ross Marshall, Vice President Healthcare at The Equicom Group, has now been published. Click here to download the full report (pdf). The public Canadian healthcare sector started 2011 with a steady but relatively quiet flow of events until Valeant Pharmaceuticals announced that it had [...]

Friday Science Review: April 22, 2011

Fibroblast Growth Factor 9 Helps Form Vasoreactive Vessels University of Western Ontario ♦ Published in Nature Biotechnology, April 17, 2011 Some interesting findings from the University of Western Ontario could have implications for future angiogenesis therapies and tissue engineering approaches to the treatment of vascular disease. Researchers discovered that fibroblast growth factor 9 (FGF9), an [...]

Monday Biotech Deal Review: April 18, 2011

Welcome to your Monday Biotech Deal Review for April 18, 2011.  Just by way of FYI, readers may be interested to know that The Canadian Institute will be hosting its 5th annual conference on Drug Pricing and Reimbursement in Canada in Toronto from June 14 – 15 at the Sutton Place Hotel.  The conference aims [...]

Friday Science Review: April 15, 2011

New Prognostic Signature for NSCLC The Campbell Family Cancer Research Institute ♦ University of Toronto Published in PNAS, April 7, 2011 It has long been known that the tumour microenvironment, or niche, plays a major role in the development of cancer, the progression of disease, and eventually metastasis. Non-small cell lung carcinoma (NSCLC), which accounts [...]

Monday Biotech Deal Review: April 11, 2011

Welcome to your Monday Biotech Deal Review for April 11, 2011.  Notable events in the Canadian biotech space over the past week included: (i) the filing by Valeant with the SEC of a consent solicitation statement in furtherance of its efforts to replace the board of its hostile target Cephalon; (ii) the approval by creditors [...]

Friday Science Review: April 8, 2011

Cancer Immunotherapy in the Clinic: Dendritic Cells Present the Possibility McMaster University ♦ Medical School of the Vrije Universiteit Brussel Review Published in Molecular Therapy (npg), April 5, 2011 Dendritic cells play a vital role in the generation of T-cell responses to invading pathogens in the body. They fall into a class of cells known [...]

Myriad Genetics v ACLU in the Federal Circuit

The ACLU had its day in court at the Federal Circuit yesterday, with oral arguments occupying 70 minutes of the court’s time in front of an audience of “hundreds” according to coverage from The Salt Lake Tribune (Myriad’s hometown paper). This case, you will recall, is a challenge to the patentability of isolated DNA. When [...]

Flow-Through Shares for Healthcare Part 3 of 3: What If It Actually Happens

Part 1 of this series described the basics of flow-throughs and Part 2 examined both the structure and the level of financing that flow-through shares have provided to the mining and oil & gas industries. This part analyzes the factors contributing to a decision by the government to expand flow-throughs to healthcare and biotech companies, [...]

Monday Biotech Deal Review: April 4, 2011

Welcome to your Monday Biotech Deal Review for April 4, 2011.  Valeant was a major headline last week with its hostile $5.7 billion leveraged-buyout offer for Cephalon, Inc., which some are suggesting may herald a new era of M&A activity in the biotech sector (you’ll recall that Valeant itself is the product of the recent [...]

Friday Science Review: April 1st, 2011

Temperature Sensitive Yeast Library Poised to Uncover Gene Function University of Toronto ♦ Published in Nature Biotechnology, Mar. 27, 2011 In efforts to document the roles of essential eukaryotic genes, a group of researchers at The Terrence Donnelly Centre for Cellular and Biomolecular Research have constructed an expansive library of yeast mutants that can be [...]

Follow

Get every new post delivered to your Inbox.

Join 76 other followers